Copaxone, generically known as glatiramer acetate, is an immunomodulating medication commonly prescribed for the management of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Its specific mechanism in treating MS is not fully understood, but it is believed to act by modifying the immune system’s response, thereby reducing the frequency of relapse events. Copaxone stands out for its distinctive approach to managing MS, focusing on proactive immune system modulation.